Sangamo Therapeutics (SGMOQ) Goodwill & Intangibles (2013 - 2023)

Sangamo Therapeutics' Goodwill & Intangibles history runs 11 years deep, the most recent figure standing at $51.6 million for Q1 2023.

• On a quarterly basis, Goodwill & Intangibles fell 43.73% year-over-year to $51.6 million in Q1 2023; TTM through Mar 2023 was $51.6 million, a 43.73% decrease from a year earlier, with the FY2022 full-year figure at $88.3 million, down 5.54% from the prior year.
• Goodwill & Intangibles fell to $51.6 million in Q1 2023 per SGMOQ's latest filing, from $88.3 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $100.9 million in Q4 2020 and bottomed at $51.6 million in Q1 2023.
• The 5-year median for Goodwill & Intangibles is $92.5 million (2019), against an average of $90.1 million.
• Across the five-year window, Goodwill & Intangibles jumped 5810.85% in 2019 and sank 43.73% in 2023, its largest moves.
• Year by year, Goodwill & Intangibles stood at $92.4 million in 2019, then rose by 9.19% to $100.9 million in 2020, then slipped by 7.4% to $93.5 million in 2021, then fell by 5.54% to $88.3 million in 2022, then slumped by 41.6% to $51.6 million in 2023.
• Per Business Quant, the three latest SGMOQ Goodwill & Intangibles figures stand at $51.6 million (Q1 2023), $88.3 million (Q4 2022), and $81.0 million (Q3 2022).